...
首页> 外文期刊>Analytical and bioanalytical chemistry >Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
【24h】

Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices

机译:通过现场免疫测定和使用两种不同口腔液收集装置的GC-MS分析口腔液中的大麻素

获取原文
获取原文并翻译 | 示例

摘要

Oral fluid (OF) enables non-invasive sample collection for on-site drug testing, but performance of on-site tests with occasional and frequent smokers’ OF to identify cannabinoid intake requires further evaluation. Furthermore, as far as we are aware, no studies have evaluated differences between cannabinoid disposition among OF collection devices with authentic OF samples after controlled cannabis administration. Fourteen frequent (≥4 times per week) and 10 occasional (less than twice a week) adult cannabis smokers smoked one 6.8 % Δ9-tetrahydrocannabinol (THC) cigarette ad libitum over 10 min. OF was collected with the StatSure Saliva Sampler, Oral-Eze, and Draeger DrugTest 5000 test cassette before and up to 30 h after cannabis smoking. Test cassettes were analyzed within 15 min and gas chromatography–mass spectrometry cannabinoid results were obtained within 24 h. Cannabinoid concentrations with the StatSure and Oral-Eze devices were compared and times of last cannabinoid detection (t_(last)) and DrugTest 5000 test performance were assessed for different cannabinoid cutoffs. 11-nor-9-Carboxy-THC (THCCOOH) and cannabinol concentrations were significantly higher in Oral-Eze samples than in Stat-Sure samples. DrugTest 5000 t_(last) for a positive cannabinoid test weremedian (range) 12 h (4– 24 h) and 21 h (1–≥30 h) for occasional and frequent smokers, respectively. Detection windows in screening and confirmatory tests were usually shorter for occasional than for frequent smokers, especially when including THCCOOH ≥20 ng L?1 in confirmation criteria. No differences in t_(last) were observed between collection devices, except for THC ≥2 μgL~(?1).We thus report significantly different THCCOOH and cannabinol, but not THC, concentrations between OF collection devices, which may affect OF data interpretation. The DrugTest 5000 on-site device had high diagnostic sensitivity, specificity, and efficiency for cannabinoids.
机译:口服液(OF)可以进行非侵入性的样本采集,以进行现场药物测试,但是对于偶尔和经常吸烟的OF来识别大麻素摄入量的现场测试,还需要进一步评估。此外,据我们所知,在控制大麻施用后,尚无研究评估具有合法OF样品的OF收集装置之间的大麻素配置差异。成年大麻吸烟者有14名频繁(≥4次,每周一次)和10次(每周少于2次)成人吸烟者在10分钟内随意抽根6.8%Δ9-四氢大麻酚(THC)香烟。在大麻吸烟之前和之后30小时,使用StatSure唾液采样器,Oral-Eze和Draeger DrugTest 5000测试盒收集OF。在15分钟内分析了测试盒,并在24小时内获得了气相色谱-质谱法大麻素结果。比较了StatSure和Oral-Eze设备的大麻素浓度,并针对不同的大麻素临界值评估了上次大麻素检测时间(t_(last))和DrugTest 5000测试性能。 Oral-Eze样品中的11-nor-9-羧基THC(THCCOOH)和大麻酚浓度显着高于Stat-Sure样品。接受大麻素试验阳性的DrugTest 5000 t_(最后)分别为偶尔吸烟和经常吸烟者的中位(范围)分别为12小时(4–24小时)和21小时(1–≥30小时)。筛查和确认测试中的检测窗口通常比经常吸烟者要短,尤其是当THCCOOH≥20 ng L?1纳入确认标准时。除THC≥2μgL〜(?1)外,各采集装置之间的t_(last)没有差异,因此我们报告了OF采集装置之间的THCCOOH和大麻酚浓度有显着差异,但THC浓度没有差异,这可能影响OF数据解释。 DrugTest 5000现场设备对大麻素具有很高的诊断灵敏度,特异性和效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号